Logo image of STUD.CA

STALLION URANIUM CORP (STUD.CA) Stock Fundamental Analysis

Canada - TSX Venture Exchange - TSX-V:STUD - CA8529192087 - Common Stock

0.43 CAD
+0.01 (+2.38%)
Last: 11/21/2025, 7:00:00 PM
Fundamental Rating

2

Overall STUD gets a fundamental rating of 2 out of 10. We evaluated STUD against 215 industry peers in the Oil, Gas & Consumable Fuels industry. No worries on liquidiy or solvency for STUD as it has an excellent financial health rating, but there are worries on the profitability. STUD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year STUD has reported negative net income.
In the past year STUD has reported a negative cash flow from operations.
STUD had negative earnings in each of the past 5 years.
In the past 5 years STUD always reported negative operating cash flow.
STUD.CA Yearly Net Income VS EBIT VS OCF VS FCFSTUD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -139.97%, STUD is doing worse than 85.12% of the companies in the same industry.
STUD has a worse Return On Equity (-147.46%) than 78.14% of its industry peers.
Industry RankSector Rank
ROA -139.97%
ROE -147.46%
ROIC N/A
ROA(3y)-61.91%
ROA(5y)-42.67%
ROE(3y)-74.25%
ROE(5y)-51.05%
ROIC(3y)N/A
ROIC(5y)N/A
STUD.CA Yearly ROA, ROE, ROICSTUD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

STUD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STUD.CA Yearly Profit, Operating, Gross MarginsSTUD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

8

2. Health

2.1 Basic Checks

The number of shares outstanding for STUD has been increased compared to 1 year ago.
STUD has more shares outstanding than it did 5 years ago.
STUD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
STUD.CA Yearly Shares OutstandingSTUD.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
STUD.CA Yearly Total Debt VS Total AssetsSTUD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

An Altman-Z score of 50.74 indicates that STUD is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 50.74, STUD belongs to the top of the industry, outperforming 98.60% of the companies in the same industry.
There is no outstanding debt for STUD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 50.74
ROIC/WACCN/A
WACCN/A
STUD.CA Yearly LT Debt VS Equity VS FCFSTUD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

STUD has a Current Ratio of 2.75. This indicates that STUD is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.75, STUD belongs to the best of the industry, outperforming 84.65% of the companies in the same industry.
STUD has a Quick Ratio of 2.75. This indicates that STUD is financially healthy and has no problem in meeting its short term obligations.
STUD's Quick ratio of 2.75 is amongst the best of the industry. STUD outperforms 85.58% of its industry peers.
Industry RankSector Rank
Current Ratio 2.75
Quick Ratio 2.75
STUD.CA Yearly Current Assets VS Current LiabilitesSTUD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

0

3. Growth

3.1 Past

STUD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -380.51%.
EPS 1Y (TTM)-380.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.77%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for STUD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
STUD.CA Price Earnings VS Forward Price EarningsSTUD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STUD.CA Per share dataSTUD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

STUD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STALLION URANIUM CORP

TSX-V:STUD (11/21/2025, 7:00:00 PM)

0.43

+0.01 (+2.38%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-27 2025-08-27
Earnings (Next)11-27 2025-11-27
Inst Owners0.12%
Inst Owner ChangeN/A
Ins Owners17.2%
Ins Owner ChangeN/A
Market Cap56.06M
Revenue(TTM)N/A
Net Income(TTM)-17.10M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.83
P/tB 4.83
EV/EBITDA N/A
EPS(TTM)-0.56
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -139.97%
ROE -147.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-61.91%
ROA(5y)-42.67%
ROE(3y)-74.25%
ROE(5y)-51.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.75
Quick Ratio 2.75
Altman-Z 50.74
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-380.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y17.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.01%
OCF growth 3YN/A
OCF growth 5YN/A

STALLION URANIUM CORP / STUD.CA FAQ

What is the ChartMill fundamental rating of STALLION URANIUM CORP (STUD.CA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to STUD.CA.


What is the valuation status for STUD stock?

ChartMill assigns a valuation rating of 0 / 10 to STALLION URANIUM CORP (STUD.CA). This can be considered as Overvalued.


Can you provide the profitability details for STALLION URANIUM CORP?

STALLION URANIUM CORP (STUD.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for STUD stock?

The financial health rating of STALLION URANIUM CORP (STUD.CA) is 8 / 10.